search
Back to results

Descriptive Study of Drug Compliance in Uncontrolled Hypertensive Patients (THERMO-HTA)

Primary Purpose

Uncontrolled Hypertension

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
assessment of drug compliance
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Uncontrolled Hypertension focused on measuring drug compliance, hypertension, anti-hypertensive agents

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patient treated with diuretics and / or beta-blockers and / or calcium-blockers and / or ACE inhibitors and / or sartans
  • Holter blood pressure total average of 24h greater than 135/85 mmHg or a daytime average greater than 140/90 mmHg or a nighttime average greater than 125/75 mmHg.
  • informed consent given

Exclusion Criteria:

  • Adults with severe hypertension (BP ≥ 180/110 mmHg) with or without organ failure requiring therapeutic adaptation
  • Adults unable to comply with study procedures
  • Patients who do not wish to receive generic drugs.

Sites / Locations

  • Hôpital Louis Pradel

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

cohort of uncontrolled hypertensive patients

Arm Description

Outcomes

Primary Outcome Measures

individual pattern of drug compliance
compliance measurement using electronic monitoring devices

Secondary Outcome Measures

Percentage of Prescribed Dosing Days with Correct Intake
The percentage of days with accurate dose intake is defined according to the reference: Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997 Jun;18(3):187-203.
Percentage of Prescribed Dose Taken
This measure, though often close to the previous one, focuses on the dose actually received and is defined according to the reference: Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997 Jun;18(3):187-203.
Percentage of Drug Holidays
We define a "drug holiday" as a period of one or more days without drug intake (that is, without MEMS (Medication Event Monitoring System) opening). The statistic counts the number of gaps among the prescribed days, ignoring the length of each individual gap, according to the reference: Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997 Jun;18(3):187-203.
Time Variability in Drug Intake
summary measures consider only the number of medication events each day, according to the reference: Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997 Jun;18(3):187-203.

Full Information

First Posted
November 16, 2017
Last Updated
June 17, 2022
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT03348878
Brief Title
Descriptive Study of Drug Compliance in Uncontrolled Hypertensive Patients
Acronym
THERMO-HTA
Official Title
Drug Compliance of Patients With Uncontrolled Hypertension Under Treatment: a Pilot Study (Descriptive, Prospective, Monocentric Cohort)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Terminated
Why Stopped
only 4 patients
Study Start Date
December 16, 2019 (Actual)
Primary Completion Date
March 23, 2022 (Actual)
Study Completion Date
March 23, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Therapeutic compliance is defined as the degree of coincidence between a person's behavior and prescribing advice given by his or her physician. According to the World Health Organization (WHO), "insufficient adherence is the main reason why patients do not get all the benefits they could expect from their medicines. It causes medical and psychosocial complications, diminishes the quality of life of patients, increases the likelihood of drug resistance, and waste of resources. " In the case of certain conditions such as high blood pressure (hypertension), poor adherence increases the risk of stroke, acute coronary syndrome, and heart failure. In patients with uncontrolled hypertension under treatment, the issue of therapeutic non-compliance should always be considered before considering the dose (supplemental drug) of antihypertensive therapy. For each patient participating in the study, medication adherence (for one of the antihypertensive treatments) will be assessed for 2 months using an electronic pill. The antihypertensive treatments considered for the study belong to the following classes: diuretics, beta-blockers, calcium-blockers, ACE (angiotensin-converting enzyme) inhibitors, sartans. Main objective: care objective: to provide physicians and patients with assistance in case of ineffectiveness or therapeutic escape in a chronic disease such as hypertension, by assessing the compliance profile of each patient. Secondary objectives: to carry out a quantitative typology of drug adherence in patients with unbalanced HTA under treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Uncontrolled Hypertension
Keywords
drug compliance, hypertension, anti-hypertensive agents

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Arm Title
cohort of uncontrolled hypertensive patients
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
assessment of drug compliance
Intervention Description
assessment of drug compliance using electronic monitoring devices (2 months duration)
Primary Outcome Measure Information:
Title
individual pattern of drug compliance
Description
compliance measurement using electronic monitoring devices
Time Frame
2 months of follow-up
Secondary Outcome Measure Information:
Title
Percentage of Prescribed Dosing Days with Correct Intake
Description
The percentage of days with accurate dose intake is defined according to the reference: Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997 Jun;18(3):187-203.
Time Frame
2 months of follow-up
Title
Percentage of Prescribed Dose Taken
Description
This measure, though often close to the previous one, focuses on the dose actually received and is defined according to the reference: Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997 Jun;18(3):187-203.
Time Frame
2 months of follow-up
Title
Percentage of Drug Holidays
Description
We define a "drug holiday" as a period of one or more days without drug intake (that is, without MEMS (Medication Event Monitoring System) opening). The statistic counts the number of gaps among the prescribed days, ignoring the length of each individual gap, according to the reference: Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997 Jun;18(3):187-203.
Time Frame
2 months of follow-up
Title
Time Variability in Drug Intake
Description
summary measures consider only the number of medication events each day, according to the reference: Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997 Jun;18(3):187-203.
Time Frame
2 months of follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patient treated with diuretics and / or beta-blockers and / or calcium-blockers and / or ACE inhibitors and / or sartans Holter blood pressure total average of 24h greater than 135/85 mmHg or a daytime average greater than 140/90 mmHg or a nighttime average greater than 125/75 mmHg. informed consent given Exclusion Criteria: Adults with severe hypertension (BP ≥ 180/110 mmHg) with or without organ failure requiring therapeutic adaptation Adults unable to comply with study procedures Patients who do not wish to receive generic drugs.
Facility Information:
Facility Name
Hôpital Louis Pradel
City
Bron
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Descriptive Study of Drug Compliance in Uncontrolled Hypertensive Patients

We'll reach out to this number within 24 hrs